Chlamydia pneumoniae and vascular disease (Q37880177)

24 August 2017

1 reference

title

Chlamydia pneumoniae and vascular disease (English)

1 reference

24 August 2017

Chlamydia pneumoniae

1 reference

Gibbs RG

1

1 reference

24 August 2017

Carey N

series ordinal

2

1 reference

24 August 2017

Davies AH

series ordinal

3

1 reference

24 August 2017

language of work or name

English

0 references

publication date

1 September 1998

1 reference

British Journal of Surgery

24 August 2017

1 reference

24 August 2017

85

1 reference

24 August 2017

9

1 reference

24 August 2017

1191-1197

1 reference

Infections caused by Chlamydia pneumoniae strain TWAR

24 August 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1998.00861.X

A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1998.00861.X

A new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1998.00861.X

Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1998.00861.X

Chronic Chlamydia pneumoniae Infection as a Risk Factor for Coronary Heart Disease in the Helsinki Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1998.00861.X

Chlamydia pneumoniae-specific circulating immune complexes in patients with chronic coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1998.00861.X

Chlamydia pneumoniae: risk factors for seropositivity and association with coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1998.00861.X

Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1998.00861.X

Past infection by Chlamydia pneumoniae strain TWAR and asymptomatic carotid atherosclerosis. Atherosclerosis Risk in Communities (ARIC) Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1998.00861.X

Association of chlamydial infection with cerebrovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1998.00861.X

Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1998.00861.X

Detection of Chlamydia pneumoniae TWAR in human coronary atherectomy tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1998.00861.X

Chlamydia pneumoniae (TWAR) in atherosclerosis of the carotid artery

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1998.00861.X

Detection and widespread distribution of Chlamydia pneumoniae in the vascular system and its possible implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1998.00861.X

Failure to detect Chlamydia pneumoniae in coronary atheromas of patients undergoing atherectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1998.00861.X

Increased incidence of Chlamydia species within the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1998.00861.X

Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis. The Chlamydia pneumoniae/Atherosclerosis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1998.00861.X

Demonstration of Chlamydia pneumoniae in the walls of abdominal aortic aneurysms

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1998.00861.X

Detection of Chlamydia pneumoniae in human nonrheumatic stenotic aortic valves

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1998.00861.X

Chlamydia pneumoniae, cytomegalovirus, and herpes simplex virus in atherosclerosis of the carotid artery

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1998.00861.X

Detection of Chlamydia pneumoniae in atherosclerotic plaques in the walls of arteries of lower extremities from patients undergoing bypass operation for arterial obstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1998.00861.X

Endovascular presence of Chlamydia pneumoniae in patients with hemodynamically effective carotid artery stenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1998.00861.X

Cardiovascular disease risk from prior Chlamydia pneumoniae infection can be related to certain antigens recognized in the immunoblot profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1998.00861.X

Evidence of Chlamydia pneumoniae infection obtained by the polymerase chain reaction (PCR) in patients with acute myocardial infarction and coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1998.00861.X

Murine models of Chlamydia pneumoniae infection and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1998.00861.X

Chlamydia pneumoniae multiplies in human endothelial cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1998.00861.X

Infection as a risk factor for infarction and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1998.00861.X

Fibrinogen: a link between chronic infection and coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1998.00861.X

C reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1998.00861.X

Roles of infectious agents in atherosclerosis and restenosis: an assessment of the evidence and need for future research

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1998.00861.X

Growth of Chlamydia pneumoniae in cultured human peripheral blood mononuclear cells and induction of a cytokine response

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1998.00861.X

Preliminary report: effects of interleukin-1 on platelet counts

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1998.00861.X

Interleukin 1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1998.00861.X

Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1998.00861.X

Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS Pilot Study. ROXIS Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1998.00861.X

Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1998.00861.X

Aspirin and secondary mortality after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1998.00861.X

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1998.00861.X

Aspirin protects low density lipoprotein from oxidative modification

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1998.00861.X

Lipid lowering and plaque regression. New insights into prevention of plaque disruption and clinical events in coronary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1998.00861.X

Statins do more than just lower cholesterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1998.00861.X

The prevalence of peripheral arterial disease in a defined population

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1998.00861.X

Virus-induced atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1998.00861.X

Herpes simplex virus infection in human arterial cells. Implications in arteriosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1998.00861.X

10.1046/J.1365-2168.1998.00861.X

21 January 2018

Identifiers

DOI

1 reference

24 August 2017

1 reference